US Stem Cell Inc (USRM)

[a1tellem]

Basically what I thought USRM lawyers would say in regards to the attempt to block testimony of former patients.

You can’t have it both ways, either the safety is relevant or it isn’t and FDA already made it an issue, so if it’s an issue so much, then let’s get some patients in here to talk about safety and effacy. Let’s also look at our peer reviewed studies.

Touché